Accelerated Receptor Shedding Inhibits Kidney Injury Molecule-1 (KIM-1)-mediated Efferocytosis
Overview
Physiology
Authors
Affiliations
Efficient clearance of apoptotic cells (efferocytosis) prevents inflammation and permits repair following tissue injury. Kidney injury molecule-1 (KIM-1) is a receptor for phosphatidylserine, an "eat-me" signal exposed on the surface of apoptotic cells that marks them for phagocytic clearance. KIM-1 is upregulated on proximal tubule epithelial cells (PTECs) during ischemic acute kidney injury (AKI), enabling efferocytosis by surviving PTECs. KIM-1 is spontaneously cleaved at its ectodomain region to generate a soluble fragment that serves a sensitive and specific biomarker for AKI, but the biological relevance of KIM-1 shedding is unknown. Here, we sought to determine how KIM-1 shedding might regulate efferocytosis. Using cells that endogenously and exogenously express KIM-1, we found that hydrogen peroxide-mediated oxidative injury or PMA treatment accelerated KIM-1 shedding in a dose-dependent manner. KIM-1 shedding was also accelerated when apoptotic cells were added. Accelerated shedding or the presence of excess soluble KIM-1 in the extracellular milieu significantly inhibited efferocytosis. We also identified that TNF-α-converting enzyme (TACE or ADAM17) mediates both the spontaneous and PMA-accelerated shedding of KIM-1. While accelerated shedding inhibited efferocytosis, we found that spontaneous KIM-1 cleavage does not affect the phagocytic efficiency of PTECs. Our results suggest that KIM-1 shedding is accelerated by worsening cellular injury, and excess soluble KIM-1 competitively inhibits efferocytosis. These findings may be important in AKI when there is severe cellular injury.
Steinhauser C, Yakac A, Markgraf W, Kromnik S, Docke A, Talhofer P Int J Mol Sci. 2024; 25(19).
PMID: 39408610 PMC: 11476884. DOI: 10.3390/ijms251910280.
Immunoaffinity proteomics for kidney injury biomarkers in male beagle dogs.
Naboulsi W, Planatscher H, Schmidt F, Steinhilber A, Joos T, Adedeji A EXCLI J. 2024; 23:180-197.
PMID: 38487082 PMC: 10938254. DOI: 10.17179/excli2023-6621.
Szumilas D, Owczarek A, Brzozowska A, Niemir Z, Olszanecka-Glinianowicz M, Chudek J Int J Mol Sci. 2024; 25(2).
PMID: 38256147 PMC: 10816507. DOI: 10.3390/ijms25021074.
ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?.
Maas S, Donners M, van der Vorst E Int J Mol Sci. 2023; 24(8).
PMID: 37108478 PMC: 10139114. DOI: 10.3390/ijms24087309.
Huisman G, Spraakman N, Koomen J, Talsma A, Pol R, Berger S Int J Mol Sci. 2023; 24(6).
PMID: 36982720 PMC: 10054503. DOI: 10.3390/ijms24065649.